Clinical Trial Update: Mechanisms of Diuretic Resistance in Heart Failure, Aim 3 [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial at Yale University is investigating mechanisms of diuretic resistance in heart failure (Aim 3) and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diuretic Resistance
• Heart Failure

Snippet

Sponsor: Yale University | Conditions: Heart Failure, Diuretic Resistance | Phase 1 | Status: RECRUITING